financetom
Business
financetom
/
Business
/
CDW Faces Double Squeeze As Revenue Growth Slows And Costs Climb
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CDW Faces Double Squeeze As Revenue Growth Slows And Costs Climb
Nov 4, 2025 11:18 AM

CDW Corp. ( CDW ) shares tumbled Tuesday after the IT solutions provider beat third-quarter profit expectations but narrowly missed revenue estimates.

The company reported adjusted earnings of $2.71 per share, exceeding analysts’ estimates of $2.62, an increase from $2.63 per share in the same period a year earlier.

Net sales totaled $5.74 billion, narrowly missing the consensus forecast of $5.75 billion but up from $5.52 billion in the same period last year.

Also Read: Dell Stock Falls As Trump Administration Expands Spending Review To Tech Contracts

The rise in net sales was driven by stronger customer demand for networking products, notebooks and mobile devices, desktops, software, and services, partly offset by lower sales of data storage and servers.

Revenue expanded year-over-year, but momentum eased.

Gross profit margin edged up to 21.9% from 21.8% a year earlier, while adjusted operating margin slipped to 9.2% from 9.7%.

Total selling and administrative expenses rose 12.9% year-over-year to $812.2 million in the quarter, climbing faster than revenue and pressuring margins.

The company ended the quarter with $453.1 million in cash, cash equivalents, and restricted cash.

CDW’s board approved a quarterly cash dividend of 63 cents per share, payable on Dec. 10, 2025, to shareholders of record as of Nov. 25, 2025.

Segment Performance

CDW’s sales by business segment varied notably in the quarter. In the Corporate segment, net sales rose to $2,255 million, up 4.4% year-on-year.

The Small Business unit posted strong growth, with net sales of $434 million, an increase of 14.2% compared to the prior year.

In the Public segment, net sales were $2,350 million, up just 0.6%, reflecting growth of 7.8% in Government and 6.9% in Healthcare, partially offset by an 8.5% drop in Education sales.

Finally, in the Other category (UK & Canada operations), net sales climbed to $698 million, up 9.1% from the prior year.

CEO Commentary

Christine A. Leahy, chair and chief executive officer, CDW, stated, “The team delivered resilient performance in Q3 as we continued to guide customers through evolving market dynamics and deliver mission critical outcomes across the full IT stack and lifecycle.”

“These results underscore the strength of our diversified customer base and expansive product and solutions portfolio, enabled by our strategic investments and customer-first approach.”

Price Action: CDW shares were trading lower by 9.43% to $140.23 at last check Tuesday.

Read Next:

Hertz Stock Surges As Q3 Earnings Top Estimates

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eupraxia Pharmaceuticals Proposes Public Offering
Eupraxia Pharmaceuticals Proposes Public Offering
Mar 10, 2026
04:24 PM EDT, 09/22/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) said late Monday it has filed a preliminary prospectus supplement to its short form base shelf prospectus for a public offering of shares. The firm expects to grant its underwriters a 30-day option to buy up to an additional 15% of shares offered in the offering. Shares were...
RF Capital Group Shareholders Approve $597-Million Sale To IA Financial
RF Capital Group Shareholders Approve $597-Million Sale To IA Financial
Mar 10, 2026
04:22 PM EDT, 09/22/2025 (MT Newswires) -- RF Capital Group ( GMPFF ) on Monday said its shareholders voted to approve the $597-million sale of the wealth manager to IA Financial Corporation ( IAFNF ) . RF Capital ( GMPFF ) said 98.8% of common shares were voted in favor of the deal, which will see IA Financial ( IAFNF...
Eupraxia Pharmaceuticals Down 2.6% After Hours as It Files for Public Offering of Common Shares
Eupraxia Pharmaceuticals Down 2.6% After Hours as It Files for Public Offering of Common Shares
Mar 10, 2026
04:37 PM EDT, 09/22/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) were last seen down 2.6% in after-hours Nasdaq trading after the company on Monday said it filed a preliminary prospectus supplement for a proposed public offering of its shares. The company did not say how many shares it expects to sell in the offering or at what price,...
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform
Mar 10, 2026
04:37 PM EDT, 09/22/2025 (MT Newswires) -- Heartflow ( HTFL ) said late Monday it received US Food and Drug Administration 510(k) clearance for its next-gen Heartflow Plaque Analysis platform featuring an updated algorithm that shows a 21% improvement in plaque detection for better management and diagnosis of coronary artery disease. The latest technology also comes with an expanded nomogram...
Copyright 2023-2026 - www.financetom.com All Rights Reserved